Cardiovascular Surgery

This channel includes news and new technology innovations for cardiac surgery. This includes coronary artery bypass grafts (CABG) and surgical valve replacements.

Cardiothoracic surgeons with UofL Health – Jewish Hospital and the University of Louisville performed the world’s first Carmat Aeson bioprosthetic total artificial heart implantation in a female patient on Sept. 14, 2021. The device was small enough to fit into the woman's smaller chest cavity. The device is being tested as a bridge to heart transplant rather than use of a LVAD. Photo by UofL Health.

News | Heart Failure

First Woman in World Receives New Type of Artificial Heart

September 22, 2021 — A cardiothoracic surgical team with University of Louisville Health – Jewish Hospital has performed ...

September 22, 2021

emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS). #HRS21 #HRS2021

News | EP Lab

Spinal Cord Stimulation Helps Suppress AF in CABG Patients

August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation ...

August 03, 2021

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular assist device (LVAD). Abbott announced the same day it has the capacity to meet increased demand for LVADs as Medtronic leaves the market.

Feature | Ventricular Assist Devices (VAD) | By Dave Fornell, Editor

Medtronic Ends Sales of HVAD Ventricular Assist System

Medtronic announced in June it was stopping the sale and distribution of the Medtronic Heartware HVAD left ventricular ...

July 08, 2021

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be thwarted by infection. No matter how skilled a cardiac surgeon or how successful a surgery, when an SSI sets in, patients can find themselves fighting for their lives. While not unique to cardiovascular surgery, post-operative infections have severe repercussions for recovering heart surgery patients. Unfortunately, even with SSI prevention methods implemented, SSIs remain as common as 5% in car

Feature | Cardiovascular Surgery | By Noam Emanuel, Ph.D.

Rethinking Heart Surgery Surgical Site Infection Prevention

Surgical Site Infection (SSI) prevention remains a high priority for cardiac surgeons whose heroic efforts can be ...

June 24, 2021

The Carmat system, an experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can adjust to the changing needs of patients treated for end-stage heart failure. Outcomes in the first series of patients managed with the new heart replacement pump in Auto-Mode are presented in the journal of the American Society for Artificial Internal Organs (ASAIO).

News | Artificial Heart

Carmat Artificial Heart Shows Promising Automatic Regulation of Blood Flow

June 18, 2021 – An experimental artificial heart includes an autoregulation control mechanism, or Auto-Mode, that can ...

June 23, 2021

The LivaNova Percelval sutureless aortic valve and Solo Smart surgical aortic valve are part of heart valve portfolio the company sold off June 1 to Gyrus Capital and Corcym..

News | Heart Valve Technology

LivaNova Sells Heart Valve Business to Gyrus Capital

June 2, 2021 – LivaNova announced June 1 it successfully completed the initial closing of the divestiture of its heart ...

June 02, 2021

In the LAAOS III trial, surgeons could seal off the LAA during the open heart procedure using sutures, staples or approved closure devices. The image shows a SentraHeart lasso type LAA occluder about to seal off the LAA from the outside of the heart. #ACC21 #ACC2021

News | Left Atrial Appendage (LAA) Occluders

Left Atrial Appendage Occlusion Reduces Stroke After Heart Surgery

May 15, 2021 — Patients with an elevated risk of stroke due to heart rhythm problems, or atrial fibrillation (AFib) ...

May 15, 2021

If MitraClip Fails 95 Percent of Patients Will Need Full Surgical Valve Replacement according to a late-breaking study at the AATS 2021 meeting. #AATS2021

News | Heart Valve Technology

If MitraClip Fails 95 Percent of Patients Will Need Surgical Valve Replacement

May 4, 2021 – A new study, presented at the 2021 American Association for Thoracic Surgery (AATS) 101st annual meeting ...

May 04, 2021

The Transmedics Organ Care System (OCS) Heart, or “Heart in a Box,” enables transplant surgeons to travel to much farther destinations to procure transplant hearts by acting as a miniature intensive care unit that keeps the heart alive.

News | Cardiovascular Surgery

Heart in a Box Technology Expands Heart Transplant Window

April 5, 2021 — Smidt Heart Institute transplant surgeons Dominic Emerson, M.D., and Pedro Catarino, M.D. know how to be ...

April 05, 2021

Videos | Ventricular Assist Devices (VAD)

VIDEO: New LVAD Designed to Prevent Hemolysis and Clots

Surgeons at Penn State Heart and Vascular Institute were the second group in the nation to implant a newly-designed ...

March 22, 2021

University of Minnesota researchers used a hybrid of tissue engineering and regenerative medicine to create heart valves that can grow with the recipient. When implanted in lambs, researchers showed that the tri-tube valves worked better than current animal-derived valves with almost none of the calcification or blood clotting that the other valves showed. This can be implanted in pediatric patients with congenital heart diseas. Photo from Syedain, et al., Tranquillo Lab, University of Minnesota

News | Heart Valve Technology

Lab-created Heart Valves Can Grow With the Patient

March 18, 2020 — A groundbreaking new study led by University of Minnesota Twin Cities researchers from both the College ...

March 18, 2021

LVAD patient Richard Huggins with the external control and power unit for his new EvaHeart2 left ventricular assist device at Penn State Health's Hershey Medical Center.

News | Heart Failure

Hershey Medical Center Second in the Nation to Implant EvaHeart2 LVAD

March 2, 2021 — Penn State Health Milton S. Hershey Medical Center became the second hospital in the nation to implant a ...

March 02, 2021

News | Ventricular Assist Devices (VAD)

Medtronic Recalls HVAD Pump Implant Kits After 2 Deaths and 19 Serious Injuries

March 1, 2021 — Medtronic is recalling the HeartWare Ventricular Assist Device (HVAD) Pump Implant Kit because the left ...

March 01, 2021

Two types of cardiac output monitoring. Left, is the lithium dilution technology is used to monitor and optimize hemodynamics. Show here is the LiDCOplus technology. Right, an example of an invasive pulmonary artery (PA) catheter used for invasive right heart hemodynamic monitoring.

Feature | Hemodynamic Monitoring Systems

Trends in Cardiac Output Monitoring Device Technologies

The overall trend in the cardiac output monitoring market is a movement toward noninvasive or minimally monitoring ...

February 23, 2021

News | Artificial Heart

FDA OKs Use New Version of Carmat Artificial Heart in U.S. Early Feasibility Study

February 10, 2021 - The U.S. Food and Drug Administration (FDA) has granted artificial heart developer Carmat approval ...

February 10, 2021